Drugs / Xalost S
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04164459 | Dec 2018 → Dec 2019 | glaucoma | Taejoon Pharmaceutical Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Xalost S | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04164459 ↗ |
| Route | Topical | “One drop one times a day in study eye” NCT04164459 ↗ |